Natural and synthetic prion structure from X-ray fiber diffraction.

PubWeight™: 1.97‹?› | Rank: Top 2%

🔗 View Article (PMC 2761340)

Published in Proc Natl Acad Sci U S A on September 28, 2009

Authors

Holger Wille1, Wen Bian, Michele McDonald, Amy Kendall, David W Colby, Lillian Bloch, Julian Ollesch, Alexander L Borovinskiy, Fred E Cohen, Stanley B Prusiner, Gerald Stubbs

Author Affiliations

1: Institute for Neurodegenerative Diseases, Departments of Neurology and Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94143, USA.

Articles citing this

Recombinant prion protein induces a new transmissible prion disease in wild-type animals. Acta Neuropathol (2010) 3.19

Prions. Cold Spring Harb Perspect Biol (2011) 3.17

Purified and synthetic Alzheimer's amyloid beta (Aβ) prions. Proc Natl Acad Sci U S A (2012) 2.36

Structural organization of brain-derived mammalian prions examined by hydrogen-deuterium exchange. Nat Struct Mol Biol (2011) 1.90

Biology and genetics of prions causing neurodegeneration. Annu Rev Genet (2013) 1.63

Amyloid structure: conformational diversity and consequences. Annu Rev Biochem (2011) 1.57

The α-helical C-terminal domain of full-length recombinant PrP converts to an in-register parallel β-sheet structure in PrP fibrils: evidence from solid state nuclear magnetic resonance. Biochemistry (2010) 1.53

Genesis of mammalian prions: from non-infectious amyloid fibrils to a transmissible prion disease. PLoS Pathog (2011) 1.53

The strain-encoded relationship between PrP replication, stability and processing in neurons is predictive of the incubation period of disease. PLoS Pathog (2011) 1.49

A new mechanism for transmissible prion diseases. J Neurosci (2012) 1.25

De novo generation of prion strains. Nat Rev Microbiol (2011) 1.17

Two amyloid States of the prion protein display significantly different folding patterns. J Mol Biol (2010) 1.16

High-resolution structure of infectious prion protein: the final frontier. Nat Struct Mol Biol (2012) 1.09

Spontaneous generation of anchorless prions in transgenic mice. Proc Natl Acad Sci U S A (2011) 1.08

Prions and the potential transmissibility of protein misfolding diseases. Annu Rev Microbiol (2013) 1.04

Crystallographic studies of prion protein (PrP) segments suggest how structural changes encoded by polymorphism at residue 129 modulate susceptibility to human prion disease. J Biol Chem (2010) 1.01

Prion fibrillization is mediated by a native structural element that comprises helices H2 and H3. J Biol Chem (2010) 1.00

Tau Trimers Are the Minimal Propagation Unit Spontaneously Internalized to Seed Intracellular Aggregation. J Biol Chem (2015) 0.98

Convergent replication of mouse synthetic prion strains. Am J Pathol (2013) 0.98

Atomic structures suggest determinants of transmission barriers in mammalian prion disease. Biochemistry (2011) 0.93

Heterogeneous seeding of a prion structure by a generic amyloid form of the fungal prion-forming domain HET-s(218-289). J Biol Chem (2013) 0.92

The evolution of transmissible prions: the role of deformed templating. PLoS Pathog (2013) 0.91

Conformational basis for asymmetric seeding barrier in filaments of three- and four-repeat tau. J Am Chem Soc (2012) 0.91

Degradation of fungal prion HET-s(218-289) induces formation of a generic amyloid fold. Biophys J (2012) 0.91

Burial of the polymorphic residue 129 in amyloid fibrils of prion stop mutants. J Biol Chem (2012) 0.89

Live imaging of prions reveals nascent PrPSc in cell-surface, raft-associated amyloid strings and webs. J Cell Biol (2014) 0.88

Generation of prions in vitro and the protein-only hypothesis. Prion (2010) 0.88

Prions and Protein Assemblies that Convey Biological Information in Health and Disease. Neuron (2016) 0.87

Fungal prion HET-s as a model for structural complexity and self-propagation in prions. Proc Natl Acad Sci U S A (2014) 0.87

Structural organization of mammalian prions as probed by limited proteolysis. PLoS One (2012) 0.87

A novel expression system for production of soluble prion proteins in E. coli. Microb Cell Fact (2012) 0.86

Determination of amyloid core structure using chemical shifts. Protein Sci (2012) 0.85

The Structural Architecture of an Infectious Mammalian Prion Using Electron Cryomicroscopy. PLoS Pathog (2016) 0.85

Genesis of tramsmissible protein states via deformed templating. Prion (2012) 0.84

Molecular modeling of the misfolded insulin subunit and amyloid fibril. Biophys J (2009) 0.83

Prion Protein-Antibody Complexes Characterized by Chromatography-Coupled Small-Angle X-Ray Scattering. Biophys J (2015) 0.83

Structure-Based Drug Discovery for Prion Disease Using a Novel Binding Simulation. EBioMedicine (2016) 0.83

Fiber diffraction of the prion-forming domain HET-s(218-289) shows dehydration-induced deformation of a complex amyloid structure. Biochemistry (2014) 0.83

Integrity of helix 2-helix 3 domain of the PrP protein is not mandatory for prion replication. J Biol Chem (2012) 0.82

Exploring the sequence-structure relationship for amyloid peptides. Biochem J (2013) 0.82

SAXS structural study of PrP(Sc) reveals ~11 nm diameter of basic double intertwined fibers. Prion (2013) 0.82

Prion protein misfolding, strains, and neurotoxicity: an update from studies on Mammalian prions. Int J Cell Biol (2013) 0.82

The many shades of prion strain adaptation. Prion (2014) 0.82

Structural studies of truncated forms of the prion protein PrP. Biophys J (2015) 0.81

Neutron fibre diffraction studies of amyloid using H2O/D2O isotopic replacement. Acta Crystallogr Sect F Struct Biol Cryst Commun (2011) 0.80

The diversity and relationship of prion protein self-replicating states. Virus Res (2014) 0.80

Two alternative pathways for generating transmissible prion disease de novo. Acta Neuropathol Commun (2015) 0.80

Generic amyloidogenicity of mammalian prion proteins from species susceptible and resistant to prions. Sci Rep (2015) 0.79

Multifaceted Role of Sialylation in Prion Diseases. Front Neurosci (2016) 0.79

Progress towards structural understanding of infectious sheep PrP-amyloid. Prion (2014) 0.78

Two misfolding routes for the prion protein around pH 4.5. PLoS Comput Biol (2013) 0.78

Heterogeneous seeding of HET-s(218-289) and the mutability of prion structures. Prion (2014) 0.78

Glycosylphosphatidylinositol anchoring directs the assembly of Sup35NM protein into non-fibrillar, membrane-bound aggregates. J Biol Chem (2014) 0.78

The structure of human prions: from biology to structural models-considerations and pitfalls. Viruses (2014) 0.78

Mechanism of scrapie prion precipitation with phosphotungstate anions. ACS Chem Biol (2015) 0.78

Use of proteinase K nonspecific digestion for selective and comprehensive identification of interpeptide cross-links: application to prion proteins. Mol Cell Proteomics (2012) 0.77

Sialylation of Glycosylphosphatidylinositol (GPI) Anchors of Mammalian Prions Is Regulated in a Host-, Tissue-, and Cell-specific Manner. J Biol Chem (2016) 0.77

Contrasting Effects of Two Lipid Cofactors of Prion Replication on the Conformation of the Prion Protein. PLoS One (2015) 0.77

Techniques to elucidate the conformation of prions. World J Biol Chem (2015) 0.76

Interaction of human laminin receptor with Sup35, the [PSI⁺] prion-forming protein from S. cerevisiae: a yeast model for studies of LamR interactions with amyloidogenic proteins. PLoS One (2014) 0.76

Mammalian prions: tolerance to sequence changes-how far? Prion (2012) 0.76

Amyloid structure exhibits polymorphism on multiple length scales in human brain tissue. Sci Rep (2016) 0.75

Truncated forms of the prion protein PrP demonstrate the need for complexity in prion structure. Prion (2015) 0.75

Smooth muscle titin forms in vitro amyloid aggregates. Biosci Rep (2016) 0.75

Elucidating the structure of an infectious protein. PLoS Pathog (2017) 0.75

The Priority position paper: Protecting Europe's food chain from prions. Prion (2016) 0.75

A 31-residue peptide induces aggregation of tau's microtubule-binding region in cells. Nat Chem (2017) 0.75

Reversible unfolding of infectious prion assemblies reveals the existence of an oligomeric elementary brick. PLoS Pathog (2017) 0.75

Articles cited by this

SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis (1997) 57.27

Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem (2006) 22.87

The X-ray interpretation of denaturation and the structure of the seed globulins. Biochem J (1935) 17.24

Structure of the cross-beta spine of amyloid-like fibrils. Nature (2005) 11.56

Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A (1993) 10.36

Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature (2007) 10.02

Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med (1998) 9.01

Scrapie prions aggregate to form amyloid-like birefringent rods. Cell (1983) 7.92

Synthetic mammalian prions. Science (2004) 7.35

Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J Mol Biol (1997) 7.27

Amyloid fibrils of the HET-s(218-289) prion form a beta solenoid with a triangular hydrophobic core. Science (2008) 5.55

Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry (1991) 5.53

Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J (1996) 5.50

X-ray diffraction studies on amyloid filaments. J Histochem Cytochem (1968) 4.54

Further purification and characterization of scrapie prions. Biochemistry (1982) 4.01

Amyloid fibers are water-filled nanotubes. Proc Natl Acad Sci U S A (2002) 3.78

Evidence for assembly of prions with left-handed beta-helices into trimers. Proc Natl Acad Sci U S A (2004) 3.64

Volume changes on protein folding. Structure (1994) 3.54

Pathway complexity of prion protein assembly into amyloid. J Biol Chem (2002) 2.96

Structural studies of the scrapie prion protein by electron crystallography. Proc Natl Acad Sci U S A (2002) 2.91

"Cross-beta" conformation in proteins. J Mol Biol (1968) 2.83

Structure of beta-crystallite assemblies formed by Alzheimer beta-amyloid protein analogues: analysis by x-ray diffraction. Biophys J (1993) 2.77

Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc Natl Acad Sci U S A (2006) 2.69

Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure. Proc Natl Acad Sci U S A (2007) 2.55

Ribonucleic acid components of BAI strain A (myeloblastosis) avian tumor virus. Cancer Res (1967) 2.53

Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis. J Virol (1991) 2.11

Scrapie-associated fibrils in Creutzfeldt-Jakob disease. Nature (1984) 2.11

Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59fyn and to enhance neurite outgrowth. J Cell Biol (2005) 2.00

beta-Helix is a likely core structure of yeast prion Sup35 amyloid fibers. Biochem Biophys Res Commun (2004) 1.83

X-ray diffraction of scrapie prion rods and PrP peptides. J Mol Biol (1995) 1.47

Search for a prion-specific nucleic acid. J Virol (2005) 1.44

Site-specific characterization of the N-linked glycans of murine prion protein by high-performance liquid chromatography/electrospray mass spectrometry and exoglycosidase digestions. Biochemistry (1999) 1.40

Murine amyloid fibril protein: isolation, purification and characterization. J Histochem Cytochem (1971) 1.17

Elongated oligomers assemble into mammalian PrP amyloid fibrils. J Mol Biol (2006) 1.10

Structural properties of Gerstmann-Straussler-Scheinker disease amyloid protein. J Biol Chem (2003) 1.06

Structural properties of prion protein protofibrils and fibrils: an experimental assessment of atomic models. Biochemistry (2006) 1.04

Electron crystallography of the scrapie prion protein complexed with heavy metals. Arch Biochem Biophys (2007) 1.03

Structural changes in a hydrophobic domain of the prion protein induced by hydration and by ala-->Val and pro-->Leu substitutions. J Mol Biol (2000) 1.00

The chemistry of copper binding to PrP: is there sufficient evidence to elucidate a role for copper in protein function? Biochem J (2008) 0.96

Molecular modelling indicates that the pathological conformations of prion proteins might be beta-helical. Biochem J (1999) 0.90

X-ray studies on phospholipid bilayers. II. Polymorphic forms of dipalmitoyl phosphatidylethanolamine. Z Naturforsch C (1983) 0.84

X-ray studies on phospholipid bilayers. I. Polymorphic forms of dimyristoyl lecithin. Z Naturforsch C (1982) 0.84

Structural features of prions explored by sequence analysis. II. A PrP(Sc) model. Cell Mol Life Sci (2002) 0.80

X-ray and computer modeling studies on gellan-related polymers: molecular structures of welan, S-657, and rhamsan. Carbohydr Res (1991) 0.78

Articles by these authors

Synthetic mammalian prions. Science (2004) 7.35

Expression profiling of the schizont and trophozoite stages of Plasmodium falciparum with a long-oligonucleotide microarray. Genome Biol (2003) 4.24

Evidence for assembly of prions with left-handed beta-helices into trimers. Proc Natl Acad Sci U S A (2004) 3.64

A change in the conformation of prions accompanies the emergence of a new prion strain. Neuron (2002) 3.36

GPCRDB information system for G protein-coupled receptors. Nucleic Acids Res (2003) 3.34

Prions. Cold Spring Harb Perspect Biol (2011) 3.17

Automated extraction of mutation data from the literature: application of MuteXt to G protein-coupled receptors and nuclear hormone receptors. Bioinformatics (2004) 3.03

Small-molecule aggregates inhibit amyloid polymerization. Nat Chem Biol (2008) 2.98

Pathway complexity of prion protein assembly into amyloid. J Biol Chem (2002) 2.96

Structural studies of the scrapie prion protein by electron crystallography. Proc Natl Acad Sci U S A (2002) 2.91

Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc Natl Acad Sci U S A (2006) 2.69

Design and construction of diverse mammalian prion strains. Proc Natl Acad Sci U S A (2009) 2.41

Analysis of proteome dynamics in the mouse brain. Proc Natl Acad Sci U S A (2010) 2.37

Purified and synthetic Alzheimer's amyloid beta (Aβ) prions. Proc Natl Acad Sci U S A (2012) 2.36

Conformational diversity of wild-type Tau fibrils specified by templated conformation change. J Biol Chem (2008) 2.34

Prion detection by an amyloid seeding assay. Proc Natl Acad Sci U S A (2007) 2.34

Strain-specified characteristics of mouse synthetic prions. Proc Natl Acad Sci U S A (2005) 2.25

Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice. Nat Biotechnol (2002) 2.24

Transmission and detection of prions in feces. J Infect Dis (2008) 2.20

Transmission of multiple system atrophy prions to transgenic mice. Proc Natl Acad Sci U S A (2013) 2.19

Protease-sensitive synthetic prions. PLoS Pathog (2010) 2.14

Diagnosis of human prion disease. Proc Natl Acad Sci U S A (2005) 2.13

Asymptomatic deer excrete infectious prions in faeces. Nature (2009) 2.10

Searching for new antimalarial therapeutics amongst known drugs. Chem Biol Drug Des (2006) 2.10

Mutant PrPSc conformers induced by a synthetic peptide and several prion strains. J Virol (2004) 2.07

Transmission of elk and deer prions to transgenic mice. J Virol (2006) 2.03

Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene. Proc Natl Acad Sci U S A (2003) 2.01

Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target. Proc Natl Acad Sci U S A (2005) 1.91

Prion clearance in bigenic mice. J Gen Virol (2005) 1.79

Co-evolutionary analysis reveals insights into protein-protein interactions. J Mol Biol (2002) 1.77

Conformational transformation and selection of synthetic prion strains. J Mol Biol (2011) 1.66

Copper coordination in the full-length, recombinant prion protein. Biochemistry (2003) 1.66

Dominant-negative inhibition of prion replication in transgenic mice. Proc Natl Acad Sci U S A (2002) 1.65

Synthesis and structure-activity relationship study of potent trypanocidal thio semicarbazone inhibitors of the trypanosomal cysteine protease cruzain. J Med Chem (2002) 1.64

Time-controlled transcardiac perfusion cross-linking for the study of protein interactions in complex tissues. Nat Biotechnol (2004) 1.63

Measuring prions by bioluminescence imaging. Proc Natl Acad Sci U S A (2009) 1.59

Continuous quinacrine treatment results in the formation of drug-resistant prions. PLoS Pathog (2009) 1.58

Is Parkinson's disease a prion disorder? Proc Natl Acad Sci U S A (2009) 1.56

Polio and Nobel prizes: looking back 50 years. Ann Neurol (2007) 1.54

Genes contributing to prion pathogenesis. J Gen Virol (2008) 1.51

Trafficking of prion proteins through a caveolae-mediated endosomal pathway. J Cell Biol (2003) 1.51

Discovery of 2-aminothiazoles as potent antiprion compounds. J Virol (2009) 1.51

Prion proteins in subpopulations of white blood cells from patients with sporadic Creutzfeldt-Jakob disease. Lab Invest (2009) 1.48

Prions in skeletal muscle. Proc Natl Acad Sci U S A (2002) 1.48

Automatic extraction of protein point mutations using a graph bigram association. PLoS Comput Biol (2007) 1.48

Molecular phylogeny and evolution of the plant-specific seven-transmembrane MLO family. J Mol Evol (2003) 1.45

Recombinant prion protein induces rapid polarization and development of synapses in embryonic rat hippocampal neurons in vitro. J Neurochem (2005) 1.45

Search for a prion-specific nucleic acid. J Virol (2005) 1.44

Mechanisms of prion protein assembly into amyloid. Proc Natl Acad Sci U S A (2008) 1.43

Transmission barriers for bovine, ovine, and human prions in transgenic mice. J Virol (2005) 1.43

Inactivation of prions by acidic sodium dodecyl sulfate. J Virol (2006) 1.43

Bioluminescence imaging of Abeta deposition in bigenic mouse models of Alzheimer's disease. Proc Natl Acad Sci U S A (2011) 1.39

Cytosolic prion protein in neurons. J Neurosci (2003) 1.34

Potent inhibition of scrapie prion replication in cultured cells by bis-acridines. Proc Natl Acad Sci U S A (2003) 1.32

A data processing pipeline for mammalian proteome dynamics studies using stable isotope metabolic labeling. Mol Cell Proteomics (2011) 1.31

Cell division modulates prion accumulation in cultured cells. Proc Natl Acad Sci U S A (2007) 1.25

Locally disordered conformer of the hamster prion protein: a crucial intermediate to PrPSc? Biochemistry (2002) 1.24

Prion uptake in the gut: identification of the first uptake and replication sites. PLoS Pathog (2011) 1.21

2-Aminothiazoles as therapeutic leads for prion diseases. J Med Chem (2011) 1.19

Notch-1 activation and dendritic atrophy in prion disease. Proc Natl Acad Sci U S A (2005) 1.17

De novo generation of prion strains. Nat Rev Microbiol (2011) 1.17

Transmission of scrapie and sheep-passaged bovine spongiform encephalopathy prions to transgenic mice expressing elk prion protein. J Gen Virol (2009) 1.15

The neurodegeneration sequence in prion diseases: evidence from functional, morphological and ultrastructural studies of the GABAergic system. J Neuropathol Exp Neurol (2004) 1.14

De novo design of conformationally flexible transmembrane peptides driving membrane fusion. Proc Natl Acad Sci U S A (2004) 1.14

Resistance of bovine spongiform encephalopathy (BSE) prions to inactivation. PLoS Pathog (2008) 1.14

Assembly of natural and recombinant prion protein into fibrils. Biol Chem (2005) 1.13

Cryo-immunogold electron microscopy for prions: toward identification of a conversion site. J Neurosci (2008) 1.12

Drug resistance confounding prion therapeutics. Proc Natl Acad Sci U S A (2013) 1.10

Spontaneous generation of anchorless prions in transgenic mice. Proc Natl Acad Sci U S A (2011) 1.08

Thioaptamer interactions with prion proteins: sequence-specific and non-specific binding sites. J Mol Biol (2007) 1.07

Human prion strain selection in transgenic mice. Ann Neurol (2010) 1.06

Directed evolution of an anti-prion protein scFv fragment to an affinity of 1 pM and its structural interpretation. J Mol Biol (2006) 1.06

Structure-activity relationship study of prion inhibition by 2-aminopyridine-3,5-dicarbonitrile-based compounds: parallel synthesis, bioactivity, and in vitro pharmacokinetics. J Med Chem (2007) 1.05

Toward the synthesis of artificial proteins: the discovery of an amphiphilic helical peptoid assembly. Chem Biol (2002) 1.05

Colloid formation by drugs in simulated intestinal fluid. J Med Chem (2010) 1.04

Differences between the prion protein and its homolog Doppel: a partially structured state with implications for scrapie formation. J Mol Biol (2002) 1.04

The peculiar nature of unfolding of the human prion protein. Protein Sci (2004) 1.04

Spontaneous generation of rapidly transmissible prions in transgenic mice expressing wild-type bank vole prion protein. Proc Natl Acad Sci U S A (2012) 1.03

Electron crystallography of the scrapie prion protein complexed with heavy metals. Arch Biochem Biophys (2007) 1.03

A unique sequence motif in the 54-kDa subunit of the chloroplast signal recognition particle mediates binding to the 43-kDa subunit. J Biol Chem (2005) 1.03

Salivary prions in sheep and deer. Prion (2012) 1.02

Prion infection of mouse neurospheres. Proc Natl Acad Sci U S A (2006) 1.01